Two Seas Capital LP Adaptimmune Therapeutics PLC Transaction History
Two Seas Capital LP
- $5.37 Billion
- Q2 2025
A detailed history of Two Seas Capital LP transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Two Seas Capital LP holds 22,580,701 shares of ADAP stock, worth $1.81 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
22,580,701
Previous 20,529,685
9.99%
Holding current value
$1.81 Million
Previous $4.11 Million
32.01%
% of portfolio
0.1%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding ADAP
# of Institutions
69Shares Held
116MCall Options Held
10.3KPut Options Held
0-
Eco R1 Capital, LLC San Francisco, CA27.4MShares$2.19 Million0.57% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR23.8MShares$1.9 Million0.26% of portfolio
-
Nea Management Company, LLC Timonium, MD17.1MShares$1.37 Million0.34% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.81MShares$384,7742.66% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.41MShares$352,9450.21% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $13.1M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...